If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

  • There is currently no data for POLX

London Investor Symposium

23 May 2019 07:00

RNS Number : 9058Z
Polarean Imaging PLC
23 May 2019
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

London Investor Symposium

Wednesday 12 June 2019

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces it will be hosting a Capital Markets Day for all investors on Wednesday 12 June 2019.

 

A welcome and introduction will be given by Richard Morgan, Chairman of Polarean Imaging. The morning will also feature presentations by:

 

· Bastiaan Driehuys, PhD, Founder and Chief Technology Officer

· Richard Hullihen, CEO of Polarean Imaging

· Jason Woods, PhD, Director at the Center for Pulmonary Imaging Research at Cincinnati Children's Medical Center

· Sudarshan Rajagopal, MD, PhD, Duke University (pre-recorded presentation)

 

The event will take place at the London Stock Exchange, 10 Paternoster Square, London EC4M 7LS at 9.30am, when a light breakfast will be served, for a 10.00am start. Please be aware that all visitors will require photo identification and will be subject to a brief security check on arrival to the building so allow sufficient time for this.

 

The presentations will be followed by tea and coffee, and a chance to network with all members of the Company's management team in attendance.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email polarean@walbrookpr.com.

 

Enquiries:

 

Polarean Imaging plc

www.polarean.com / www.polarean-ir.com

Richard Hullihen, Chief Executive Officer

Via Walbrook PR

Richard Morgan, Chairman

Walbrook PR

Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com

Anna Dunphy / Paul McManus

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAQLLFLKEFFBBB
Date   Source Headline
23rd Dec 20257:00 amRNSCancellation - Polarean Imaging Plc
15th Dec 20254:03 pmRNSResult of General Meeting
1st Dec 20257:00 amRNSChest coil passes Philips compatibility testing
25th Nov 20257:00 amRNSFirst Xenon Hyperpolariser in Asia
24th Nov 20257:00 amRNSKorean distributor agreement with DK Healthcare
14th Nov 20257:00 amRNSProposed Cancellation of Admission & Notice of GM
27th Oct 20253:37 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSStrategic review and consideration of AIM listing
6th Oct 20257:00 amRNSAscend Imaging agreement expansion
29th Sep 20257:00 amRNSUniversity of Virginia Health Hospital agreement
25th Sep 202512:14 pmRNSNational Institutes of Health system order
25th Sep 20257:00 amRNSHalf-year Report
16th Sep 20257:00 amRNSNotice of Results
11th Sep 20254:36 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSSubmission of new Phase III study protocol to FDA
24th Jul 20257:00 amRNSBlock Listing Six Monthly Return
24th Jun 20257:00 amRNSPromotion & sales representative agreement
9th Jun 20254:16 pmRNSResult of AGM
2nd Jun 20257:00 amRNSFDA expands XENOVIEW indication
21st May 20257:00 amRNSDr. Bastiaan Driehuys awarded by ATS
15th May 202512:48 pmRNSXenon MRI featured prominently at ATS 2025
14th May 20252:25 pmRNSOngoing collaboration with Philips
8th May 20257:00 amRNSFinal Results
6th May 20252:59 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSNotice of Results
10th Mar 20257:00 amRNSExpansion of Xenon MRI imaging platform
27th Feb 20257:00 amRNSFY24 trading update
19th Feb 20257:00 amRNSVirtual Investor Day
3rd Feb 20257:00 amRNSTaiwanese distributor agreement with Sumtage
30th Jan 20257:00 amRNSKey patent in China secured
28th Jan 20257:00 amRNSCollaboration to Advance Lung Imaging Innovation
24th Jan 20257:00 amRNSBlock Listing Six Monthly Return
11th Dec 20242:52 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFDA clears Chest Coil in GE HealthCare MRI Systems
25th Sep 20247:00 amRNSVirtual investor day
4th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20247:00 amRNSAppointment of Vice President of Sales
28th Aug 20247:00 amRNSAppointment of Chief Medical Advisor
21st Aug 20247:00 amRNSNotice of Results
15th Aug 20247:00 amRNSAppointment of Bastiaan Driehuys as consultant
1st Aug 20247:00 amRNSFDA submission to expand minimum age for XENOVIEW™
31st Jul 20247:00 amRNSNew Xenon MRI System trade-in agreement
29th Jul 20247:00 amRNSRepricing of Options and Grant of Options
26th Jul 20247:00 amRNSBlock Listing Six Monthly Return
24th Jul 20242:36 pmRNSResult of AGM
19th Jul 202410:36 amRNSXenon MRI System trade-in agreement
18th Jul 20245:33 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSFinal Results
19th Jun 20245:23 pmRNSHolding(s) in Company
19th Jun 20245:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.